Over the past 12‑18 months the Cycloaliphatic Amines Epoxy Curing Agent industry trends have accelerated through a series of strategic moves. In Q2 2024, Huntsman partnered with BASF to co‑develop a low‑VOC amine formulation targeting automotive lightweight composites, leveraging BASF’s bio‑based feedstock platform. Meanwhile, Evonik completed the acquisition of Mitsui’s specialty epoxy business for $720 million, expanding its global footprint in high‑performance aerospace applications. Early 2025 saw the launch of Dow’s “Eco‑Cure X” series, a water‑borne curing agent that delivers 30 % faster cure cycles while meeting REACH‑updated toxicity thresholds. The European Union’s revised Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) rules, effective July 2024, now require lower permissible emissions for cycloaliphatic amines, prompting manufacturers to invest in greener process technologies. In parallel, venture‑backed start‑up CuraTech secured $45 million Series B funding to scale its nanostructured curing agent line, addressing the growing demand for high‑strength, low‑shrinkage composites in electric‑vehicle battery enclosures. These developments collectively signal a shift toward sustainable, high‑efficiency solutions across automotive, aerospace, and electronics sectors.